![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RBBP9 |
Gene summary for RBBP9 |
![]() |
Gene information | Species | Human | Gene symbol | RBBP9 | Gene ID | 10741 |
Gene name | RB binding protein 9, serine hydrolase | |
Gene Alias | BOG | |
Cytomap | 20p11.23 | |
Gene Type | protein-coding | GO ID | GO:0008150 | UniProtAcc | O75884 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10741 | RBBP9 | LZE4T | Human | Esophagus | ESCC | 2.59e-04 | 2.40e-01 | 0.0811 |
10741 | RBBP9 | LZE24T | Human | Esophagus | ESCC | 2.30e-07 | 1.55e-01 | 0.0596 |
10741 | RBBP9 | LZE6T | Human | Esophagus | ESCC | 1.60e-02 | 1.25e-01 | 0.0845 |
10741 | RBBP9 | P2T-E | Human | Esophagus | ESCC | 2.32e-09 | 2.49e-01 | 0.1177 |
10741 | RBBP9 | P4T-E | Human | Esophagus | ESCC | 4.14e-07 | 1.20e-01 | 0.1323 |
10741 | RBBP9 | P5T-E | Human | Esophagus | ESCC | 2.35e-03 | 2.60e-02 | 0.1327 |
10741 | RBBP9 | P8T-E | Human | Esophagus | ESCC | 4.12e-07 | 9.17e-02 | 0.0889 |
10741 | RBBP9 | P9T-E | Human | Esophagus | ESCC | 1.05e-03 | 8.47e-02 | 0.1131 |
10741 | RBBP9 | P10T-E | Human | Esophagus | ESCC | 1.09e-06 | 1.85e-01 | 0.116 |
10741 | RBBP9 | P11T-E | Human | Esophagus | ESCC | 3.07e-04 | 2.07e-01 | 0.1426 |
10741 | RBBP9 | P12T-E | Human | Esophagus | ESCC | 5.55e-07 | 1.87e-01 | 0.1122 |
10741 | RBBP9 | P16T-E | Human | Esophagus | ESCC | 2.26e-13 | 1.97e-01 | 0.1153 |
10741 | RBBP9 | P20T-E | Human | Esophagus | ESCC | 1.08e-04 | 1.29e-01 | 0.1124 |
10741 | RBBP9 | P21T-E | Human | Esophagus | ESCC | 1.65e-16 | 3.37e-01 | 0.1617 |
10741 | RBBP9 | P22T-E | Human | Esophagus | ESCC | 7.34e-08 | 6.35e-02 | 0.1236 |
10741 | RBBP9 | P23T-E | Human | Esophagus | ESCC | 6.96e-07 | 2.12e-01 | 0.108 |
10741 | RBBP9 | P24T-E | Human | Esophagus | ESCC | 3.51e-04 | 1.19e-01 | 0.1287 |
10741 | RBBP9 | P26T-E | Human | Esophagus | ESCC | 7.64e-12 | 2.53e-01 | 0.1276 |
10741 | RBBP9 | P27T-E | Human | Esophagus | ESCC | 1.98e-09 | 1.54e-01 | 0.1055 |
10741 | RBBP9 | P28T-E | Human | Esophagus | ESCC | 1.32e-13 | 8.99e-02 | 0.1149 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Thyroid | PTC | ![]() |
Thyroid | goiters | ![]() |
Thyroid | ATC | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RBBP9 | SNV | Missense_Mutation | c.192N>G | p.His64Gln | p.H64Q | O75884 | protein_coding | tolerated(0.5) | benign(0) | TCGA-A2-A04P-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | taxol | PD | |
RBBP9 | SNV | Missense_Mutation | c.242C>A | p.Ala81Asp | p.A81D | O75884 | protein_coding | deleterious(0.02) | probably_damaging(0.983) | TCGA-AO-A03O-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | doxorubicin | SD | |
RBBP9 | SNV | Missense_Mutation | c.227N>T | p.Ser76Phe | p.S76F | O75884 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-C5-A8XJ-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Chemotherapy | cisplatin | SD | |
RBBP9 | SNV | Missense_Mutation | rs372324175 | c.326N>A | p.Arg109His | p.R109H | O75884 | protein_coding | deleterious(0.02) | benign(0.011) | TCGA-AA-3492-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
RBBP9 | SNV | Missense_Mutation | novel | c.320A>T | p.Asn107Ile | p.N107I | O75884 | protein_coding | tolerated(0.12) | benign(0.26) | TCGA-AG-A00Y-01 | Colorectum | rectum adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
RBBP9 | insertion | Frame_Shift_Ins | novel | c.458_459insATTCTACTCCTATATTG | p.Glu154PhefsTer27 | p.E154Ffs*27 | O75884 | protein_coding | TCGA-AM-5820-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
RBBP9 | SNV | Missense_Mutation | rs192424321 | c.266G>A | p.Arg89Gln | p.R89Q | O75884 | protein_coding | tolerated(0.33) | benign(0.001) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD |
RBBP9 | SNV | Missense_Mutation | rs748471993 | c.152G>A | p.Arg51Gln | p.R51Q | O75884 | protein_coding | deleterious(0.02) | benign(0.022) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD |
RBBP9 | SNV | Missense_Mutation | c.115T>C | p.Cys39Arg | p.C39R | O75884 | protein_coding | deleterious(0.01) | probably_damaging(0.999) | TCGA-D1-A0ZO-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
RBBP9 | SNV | Missense_Mutation | novel | c.198N>A | p.Asp66Glu | p.D66E | O75884 | protein_coding | deleterious(0) | possibly_damaging(0.841) | TCGA-D1-A175-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
10741 | RBBP9 | ENZYME, DRUGGABLE GENOME | inhibitor | 252166808 |
Page: 1 |